N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide

C36H30N7O4S2+ — CID 53296954

IUPACN-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide
SMILESCc1ccc2nc(-c3ccc(NC(=O)CC4C(=O)N(c5ccccc5)C(=S)N4Cc4c(NC(=O)c5ccccc5)on[n+]4C)cc3)sc2c1
InChIInChI=1S/C36H29N7O4S2/c1-22-13-18-27-30(19-22)49-34(38-27)24-14-16-25(17-15-24)37-31(44)20-28-35(46)43(26-11-7-4-8-12-26)36(48)42(28)21-29-33(47-40-41(29)2)39-32(45)23-9-5-3-6-10-23/h3-19,28H,20-21H2,1-2H3,(H-,37,38,39,40,44,45)/p+1
InChIKeyTYFSXDLYALYXLU-UHFFFAOYSA-O
MW688.82 g/mol
LogP5.87
Rot. Bonds9

About N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide

N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide (PubChem CID 53296954) has the molecular formula C36H30N7O4S2+ and a molecular weight of 688.82 g/mol. Its IUPAC name is N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide.

Molecular Properties

Compound NameN-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide
PubChem CID53296954
Molecular FormulaC36H30N7O4S2+
Molecular Weight688.82 g/mol
Exact Mass688.18
IUPAC NameN-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide
SMILESCc1ccc2nc(-c3ccc(NC(=O)CC4C(=O)N(c5ccccc5)C(=S)N4Cc4c(NC(=O)c5ccccc5)on[n+]4C)cc3)sc2c1
InChIInChI=1S/C36H29N7O4S2/c1-22-13-18-27-30(19-22)49-34(38-27)24-14-16-25(17-15-24)37-31(44)20-28-35(46)43(26-11-7-4-8-12-26)36(48)42(28)21-29-33(47-40-41(29)2)39-32(45)23-9-5-3-6-10-23/h3-19,28H,20-21H2,1-2H3,(H-,37,38,39,40,44,45)/p+1
InChIKeyTYFSXDLYALYXLU-UHFFFAOYSA-O
XLogP5.87
TPSA124.55 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds9
Heavy Atoms49
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500688.82
LogP ≤ 55.87
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide?
The IUPAC name of N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide (CID 53296954) is N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide.
What is the SMILES notation for N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide?
The canonical SMILES for N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide is Cc1ccc2nc(-c3ccc(NC(=O)CC4C(=O)N(c5ccccc5)C(=S)N4Cc4c(NC(=O)c5ccccc5)on[n+]4C)cc3)sc2c1.
What is the InChIKey of N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide?
The InChIKey is TYFSXDLYALYXLU-UHFFFAOYSA-O. The full InChI is InChI=1S/C36H29N7O4S2/c1-22-13-18-27-30(19-22)49-34(38-27)24-14-16-25(17-15-24)37-31(44)20-28-35(46)43(26-11-7-4-8-12-26)36(48)42(28)21-29-33(47-40-41(29)2)39-32(45)23-9-5-3-6-10-23/h3-19,28H,20-21H2,1-2H3,(H-,37,38,39,40,44,45)/p+1.
What are the key properties of N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide?
N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide has a molecular weight of 688.82 g/mol, XLogP of 5.87, 9 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-methyl-4-[[5-[2-[4-(6-methyl-1,3-benzothiazol-2-yl)anilino]-2-oxoethyl]-4-oxo-3-phenyl-2-sulfanylideneimidazolidin-1-yl]methyl]oxadiazol-3-ium-5-yl]benzamide is sourced from PubChem (CID 53296954), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).